# Efficacy and Tolerability of Ramelteon in Patients With Rapid Eye Movement (REM) Behavior Disorder and Parkinsonism

> **NCT00745030** · NA · TERMINATED · sponsor: **Northwestern University** · enrollment: 3 (actual)

## Conditions studied

- REM Behavior Disorder
- Parkinsonism

## Interventions

- **DRUG:** Rozerem
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00745030
- **Lead sponsor:** Northwestern University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-06
- **Primary completion:** 2009-12
- **Final completion:** 2009-12
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** Low subject recruitment and enrollment.
- **Last updated:** 2024-01-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00745030

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00745030, "Efficacy and Tolerability of Ramelteon in Patients With Rapid Eye Movement (REM) Behavior Disorder and Parkinsonism". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT00745030. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*